title: Response to Dr Fiscella: Transparency and Debate are Essential to Improve Guidelines and Measures.
authors: Center for Innovation to Implementation, VA Palo Alto Health Care System, CA Center for Innovation to Implementation, VA Palo Alto Health Care System, CA University of California, San Francisco, CA and Division of Research, Kaiser Permanente, Oakland, CA Treatment Research Institute, Philadelphia, PA Academy Health, Washington, DC Brandeis University, Waltham, MA.
authors: Alex H S
authors: AH
authors: Harris
authors: Cheng
authors: C
authors: Chen
authors: Constance M
authors: CM
authors: Weisner
authors: Mady
authors: M
authors: Chalk
authors: Victor
authors: V
authors: Capoccia
authors: Cindy Parks
authors: CP
authors: Thomas
mesh_terms: D006801:Humans; D009271:Naltrexone; D017410:Practice Guidelines as Topic / Q000592:standards
chemical_list: D009271:Naltrexone